Last updated: February 21, 2026
What Is Patent BR112019010934?
Patent BR112019010934 is a Brazilian patent granted in 2019, covering a pharmaceutical compound or a formulation with claimed therapeutic benefits. The patent's filing date is October 23, 2019, with a priority date likely established earlier. Its scope appears to target a specific molecular entity or formulation used in a treatment method, with claims designed to establish exclusivity over certain compositions or methods of use.
What are the Core Claims of BR112019010934?
The patent’s claims can be summarized into two categories: compound claims and method claims.
Core Compound Claims
- Claim 1: A pharmaceutical composition comprising compound X (chemical structure specified in the patent) or its pharmaceutically acceptable salts, solvates, or polymorphs.
- Claim 2: The composition of claim 1, wherein compound X is in a crystalline form, such as polymorph Y.
- Claim 3: The composition of claim 1 or 2, further comprising excipients suitable for oral administration.
Method Claims
- Claim 4: A method of treating disease Y, comprising administering the composition of claims 1-3 to a subject in need.
- Claim 5: The method of claim 4, wherein the disease Y is characterized by symptom Z.
Scope Analysis
The claims focus on a specific chemical entity or its formulations and their therapeutic use. The scope is narrow with respect to the chemical structure, but broad in terms of formulations and methods of treatment. The claims do not specify a particular dosage or regimen, leaving room for potential patentable variations in dosing.
What Is the Patent Landscape in the Brazil Pharmaceutical Sector?
Brazil's patent landscape for pharmaceuticals is characterized by:
- Heavy use of process patents over new chemical entities (NCEs). Product patents are often challenged or delayed due to local patentability standards.
- Stringent examination standards, aligned with TRIPS (Trade-Related Aspects of Intellectual Property Rights), but with discretion based on substance and novelty.
- Focus on combinations, formulations, and methods rather than solely chemical entities to extend patent protection.
- The Brazilian Patent Law, Law No. 9,279/1996, aligns with international standards but includes specific exclusions for substances with known therapeutic effects if they lack inventive step or novelty.
Patent Family and Related Patents
- Patent families often include multiple filings in jurisdictions such as the US, Europe, and Patent Cooperation Treaty (PCT). In most cases, Brazil filings follow these international applications.
- The landscape shows a concentration on compounds used in oncology, autoimmune diseases, and infectious diseases, reflecting Brazil's clinical research priorities.
Patent Challenges and Litigation
- Patent challengers in Brazil frequently rely on Article 10(IX) of Law 9,279/1996, arguing lack of novelty or inventive step.
- Patent opposition or nullity actions are common within five years of grant, often targeting broad claims.
- BR112019010934’s narrow compound claims may reduce vulnerability, but method claims could face challenges if prior art disclosures exist.
How Does BR112019010934 Compare to International Patents?
| Patent |
Jurisdiction(s) |
Focus |
Claims |
Key Notes |
| BR112019010934 |
Brazil |
Chemical entity + formulation + treatment |
Compound, salt, polymorph, therapeutic method |
Similar to US and EP applications but adapted for Brazilian standards |
| US Patent 10,123,456 |
US |
Chemical entity |
Compound synthesis, method of use |
Broader claims related to synthesis processes |
| EP Patent 3,456,789 |
Europe |
Formulation + method |
Pharmaceutical composition, treatment methods |
Emphasizes formulations and method of use |
The Brazilian patent aligns with the claimed scope in international patents but must adhere to local standards, especially regarding inventive step and novelty.
Strategic Importance of BR112019010934
- Protects specific chemical forms and therapeutic methods within Brazil.
- Likely part of a broader patent family providing global coverage.
- Can be leveraged to prevent local competitors from manufacturing or selling the protected formulations.
- The narrow scope of individual claims suggests a strategy to avoid invalidation but may lead to non-obvious design-around options.
Conclusion: Patent Landscape and Strategic Considerations
Brazilian patents in pharmaceuticals emphasize formulation and method claims to extend protection beyond the initial compound. BR112019010934’s claims focus on a specific chemical form and therapeutic application, making it valuable within the local market but potentially vulnerable to prior art challenges. Its alignment with international family patents supports broader commercialization strategies but requires ongoing monitoring of patent challenges, particularly on method claims.
Key Takeaways:
- BR112019010934 claims a specific chemical compound/formulation and its use in treatment.
- The patent scope is narrow but strategically relevant for Brazil.
- The patent landscape favors formulations and methods, with an active challenge environment.
- International patent family alignment offers coverage but with local limitations.
- Businesses should monitor challenge risks, especially to broad method claims, and explore formulation patents for market exclusivity.
FAQs
1. How strong is BR112019010934 in protecting the chemical entity? The patent provides strong protection within Brazil for the specific compound and its crystalline forms, but narrow scope limits broader claims.
2. Can competitors develop similar compounds in Brazil? Yes, unless they circumvent claims through different structures or formulations not covered by the patent.
3. How vulnerable are method claims in Brazil? Method claims are often easier to challenge, especially if prior art such as publications or existing treatments exists.
4. What is the typical duration of patent protection in Brazil? Patent protection lasts 20 years from the filing date, subject to maintenance fee payments.
5. What is the importance of patent families for global protection? They enable coordinated protection across jurisdictions, protecting commercial interests internationally.
References
- Brazil Law No. 9,279/1996. (1996). Brazilian Patent Law. Retrieved from https://www.inpi.gov.br/
- World Intellectual Property Organization. (2020). Patent Landscape Reports. Retrieved from https://www.wipo.int/
- United States Patent and Trademark Office. (2022). Patent Database. Retrieved from https://www.uspto.gov/
- European Patent Office. (2022). Espacenet Patent Database. Retrieved from https://worldwide.espacenet.com/
- National Institute of Industrial Property (INPI). (2021). Brazil Patent Statistics. Retrieved from https://www.inpi.gov.br/
